Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
- Status
- COMPLETED
- Phase
- PHASE2
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Blood Pressure Lowering in Acute Stroke Trial (BLAST)
- Status
- WITHDRAWN
- Phase
- NA
Lucentis Versus Mitomycin C During Glaucoma Surgery
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
- Status
- COMPLETED
- Phase
- PHASE4
A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Myfortic Conversion Trial in OLT Recipients With GI Intolerance
- Status
- COMPLETED
- Phase
- N/A
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
- Status
- COMPLETED
- Phase
- PHASE1